Caprock Group, Inc. Adaptive Biotechnologies Corp Transaction History

Caprock Group, Inc.

$2.71 Billion
Q3 2024

A detailed history of Caprock Group, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Caprock Group, Inc. holds 12,915 shares of ADPT stock, worth $82,526. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,915

Previous 12,558 2.84%

Holding current value

$82,526

Previous $45,000 46.67%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$3.37 - $5.12 $1,203 - $1,827	357 Added 2.84%	12,915 $66,000
Q2 2024 Aug 06, 2024	SELL	$2.34 - $3.96 $29,287 - $49,563	-12,516 Reduced 49.92%	12,558 $45,000
Q1 2024 Apr 29, 2024	SELL	$2.88 - $4.8 $80 - $134	-28 Reduced 0.11%	25,074 $80,000
Q4 2023 Jan 18, 2024	SELL	$3.46 - $5.33 $58 - $90	-17 Reduced 0.07%	25,102 $122,000
Q3 2023 Oct 18, 2023	SELL	$5.07 - $8.44 $1,521 - $2,532	-300 Reduced 1.18%	25,119 $136,000
Q4 2022 Jan 23, 2023	SELL	$6.26 - $9.34 $12,012 - $17,923	-1,919 Reduced 7.02%	25,419 $0
Q3 2022 Nov 07, 2022	SELL	$6.5 - $12.67 $2,691 - $5,245	-414 Reduced 1.49%	27,338 $195,000
Q2 2022 Jul 26, 2022	SELL	$6.4 - $14.73 $29,350 - $67,551	-4,586 Reduced 14.18%	27,752 $225,000
Q1 2022 Apr 12, 2022	SELL	$10.12 - $28.9 $30,359 - $86,700	-3,000 Reduced 8.49%	32,338 $449,000
Q4 2021 Jan 18, 2022	SELL	$25.17 - $36.85 $269,319 - $394,295	-10,700 Reduced 23.24%	35,338 $992,000
Q2 2021 Aug 13, 2021	SELL	$32.22 - $44.59 $96,660 - $133,770	-3,000 Reduced 6.12%	46,038 $1.88 Million
Q1 2021 Apr 29, 2021	BUY	$37.26 - $67.74 $698,923 - $1.27 Million	18,758 Added 61.95%	49,038 $1.97 Million
Q4 2020 Jan 29, 2021	SELL	$45.01 - $65.47 $469,454 - $682,852	-10,430 Reduced 25.62%	30,280 $1.79 Million
Q3 2020 Oct 29, 2020	SELL	$35.79 - $48.81 $268,425 - $366,075	-7,500 Reduced 15.56%	40,710 $1.98 Million
Q1 2020 Apr 28, 2020	BUY	$16.96 - $34.16 $689,797 - $1.39 Million	40,672 Added 539.56%	48,210 $1.34 Million
Q4 2019 Feb 04, 2020	BUY	$24.56 - $32.8 $933 - $1,246	38 Added 0.51%	7,538 $226,000
Q3 2019 Oct 31, 2019	BUY	$30.31 - $53.51 $227,325 - $401,325	7,500 New	7,500 $232,000

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Adaptive Biotechnologies Corp Transaction History